Personalized Treatment
Improving the selection of drug treatment for individual cancer patients is of high importance. The increasing numbers of treatment options in the clinic, and rapidly expanding numbers of new drugs in clinical development urge to implement novel technologies to identify the patients that benefit from it.
VitroScans’ best-in-class technology is based on ex vivo 3D tumor testing using patients derived tumor tissue. The predictive tumor testing platform is proven effective for testing (new) drugs of all therapy classes, while preserving the tumor microenvironment, and applying image based analysis to provide robust and reliable results.
